CORD-19:c654596857bce9cdd64ffc51842048643107348c / 83430-83660 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T675","span":{"begin":0,"end":230},"obj":"Sentence"},{"id":"T26020","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"When immunodeficiency is of concern, the unpredictable sensitivity of Lm should prompt in vitro assays to adjust antimicrobial therapy Problems for discussion HBV Á/HCV and liver carcinogenesis: where does the viral influence end?"}

{"project":"Epistemic_Statements","denotations":[{"id":"T129","span":{"begin":0,"end":230},"obj":"Epistemic_statement"}],"text":"When immunodeficiency is of concern, the unpredictable sensitivity of Lm should prompt in vitro assays to adjust antimicrobial therapy Problems for discussion HBV Á/HCV and liver carcinogenesis: where does the viral influence end?"}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T271","span":{"begin":0,"end":230},"obj":"Sentence"}],"text":"When immunodeficiency is of concern, the unpredictable sensitivity of Lm should prompt in vitro assays to adjust antimicrobial therapy Problems for discussion HBV Á/HCV and liver carcinogenesis: where does the viral influence end?"}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T98","span":{"begin":5,"end":21},"obj":"Phenotype"}],"attributes":[{"id":"A98","pred":"hp_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/HP_0002721"}],"text":"When immunodeficiency is of concern, the unpredictable sensitivity of Lm should prompt in vitro assays to adjust antimicrobial therapy Problems for discussion HBV Á/HCV and liver carcinogenesis: where does the viral influence end?"}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T60","span":{"begin":173,"end":178},"obj":"Body_part"}],"attributes":[{"id":"A60","pred":"uberon_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"When immunodeficiency is of concern, the unpredictable sensitivity of Lm should prompt in vitro assays to adjust antimicrobial therapy Problems for discussion HBV Á/HCV and liver carcinogenesis: where does the viral influence end?"}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T317","span":{"begin":5,"end":21},"obj":"Disease"},{"id":"T71359","span":{"begin":5,"end":21},"obj":"Disease"}],"attributes":[{"id":"A317","pred":"mondo_id","subj":"T317","obj":"http://purl.obolibrary.org/obo/MONDO_0021094"},{"id":"A71844","pred":"mondo_id","subj":"T71359","obj":"http://purl.obolibrary.org/obo/MONDO_0021094"}],"text":"When immunodeficiency is of concern, the unpredictable sensitivity of Lm should prompt in vitro assays to adjust antimicrobial therapy Problems for discussion HBV Á/HCV and liver carcinogenesis: where does the viral influence end?"}